Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Yamaguchi

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Biochemical and Biophysical Research Communications|December 23, 2008
BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosisKumi Hayashi, Toru Yamaguchi, Shozo Yano, et al.
Endocrine Journal|May 22, 2008
Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2007
The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failureShozo Yano, Toru Yamaguchi, Ippei Kanazawa, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Endocrinology|April 25, 2014
Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretionMasakazu Notsu, Toru Yamaguchi, Kyoko Okazaki, et al.
Bone|May 3, 2015
Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2Ayumu Takeno, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.
Calcified Tissue International|August 21, 2012
Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosisKyoko Okazaki, Toru Yamaguchi, Ken-Ichiro Tanaka, et al.
Journal of Pediatric Orthopedics|June 19, 2013
Sprengel deformity: morphometric assessment and surgical treatment by the modified green procedureAkifusa Wada, Tomoyuki Nakamura, Toshio Fujii, et al.
Journal of Children'S Orthopaedics|August 2, 2013
Surgical treatment of hip dislocation in Kabuki syndrome: use of incomplete periacetabular osteotomy for posterior acetabular wall deficiencyAkifusa Wada, Tomoyuki Nakamura, Toru Yamaguchi, et al.
Journal of Pediatric Orthopedics|February 5, 2026
Horizontal Cartilage Hypertrophy and Onset Age are Prognostic Indicators of Femoral Head Deformity During Containment Treatment in Legg-Calvé-Perthes DiseaseHidenao Tanaka, Ryosuke Yamaguchi, Tomoyuki Nakamura, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Biochemical and Biophysical Research Communications|December 23, 2008
BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosisKumi Hayashi, Toru Yamaguchi, Shozo Yano, et al.
Endocrine Journal|May 22, 2008
Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2007
The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failureShozo Yano, Toru Yamaguchi, Ippei Kanazawa, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Endocrinology|April 25, 2014
Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretionMasakazu Notsu, Toru Yamaguchi, Kyoko Okazaki, et al.
Bone|May 3, 2015
Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2Ayumu Takeno, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.
Calcified Tissue International|August 21, 2012
Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosisKyoko Okazaki, Toru Yamaguchi, Ken-Ichiro Tanaka, et al.
Journal of Pediatric Orthopedics|June 19, 2013
Sprengel deformity: morphometric assessment and surgical treatment by the modified green procedureAkifusa Wada, Tomoyuki Nakamura, Toshio Fujii, et al.
Journal of Children'S Orthopaedics|August 2, 2013
Surgical treatment of hip dislocation in Kabuki syndrome: use of incomplete periacetabular osteotomy for posterior acetabular wall deficiencyAkifusa Wada, Tomoyuki Nakamura, Toru Yamaguchi, et al.
Journal of Pediatric Orthopedics|February 5, 2026
Horizontal Cartilage Hypertrophy and Onset Age are Prognostic Indicators of Femoral Head Deformity During Containment Treatment in Legg-Calvé-Perthes DiseaseHidenao Tanaka, Ryosuke Yamaguchi, Tomoyuki Nakamura, et al.
Pageof 15